Concepedia

Mei Dong

MD

22

Publications

1.7K

Citations

18

H-Index

2002

Active since

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Duke Medical Center

Duke University Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Mei Dong is an author at Third Affiliated Hospital of Harbin Medical University specializing in medicine, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2002–2024

22

Publications

22

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Zhiqiang Ning, Zhibin Li, Michael Newman et al. · Cancer Chemotherapy and Pharmacology · 2011 · 284 citations

, , +9

The type III TGF-β receptor suppresses breast cancer progression

Mei Dong, Tam How, Kellye C. Kirkbride et al. · Journal of Clinical Investigation · 2006 · 253 citations · Full text

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric‐Bernstam, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 207 citations · Full text

Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion

Nadine Hempel, Tam How, Mei Dong et al. · Cancer Research · 2007 · 129 citations

, , +11

Loss of type III transforming growth factor β receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression

Kelly J. Gordon, Mei Dong, Elizabeth M. Chislock et al. · Carcinogenesis · 2007 · 124 citations · Full text

, , +18

Rows per page

1–5 of 22